Conceptio › Archive › HAL (France)
HAL (France)open access

Inflammatory Bowel Disease Patients’ Acceptance for Switching from Intravenous Infliximab or Vedolizumab to Subcutaneous Formulation: The Nancy Experience

Clotilde Remy et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
Vedolizumab, 0, Subcutaneous, Infliximab, Inflammatory bowel disease
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 643013
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.